Study that Helped Fuel Vape Fears in US Retracted following Academic Criticism

 

2019 was tumultuous year for vaping, particularly in the US where concern about e-cigarettes turned to outright panic after a wave of vape-related illnesses (since attributed to illegal, black market THC products.)  Fuelling further alarm was a report published in the summer that attempted to prove a correlation between vaping and heart attacks on par with traditional tobacco usage, findings widely disseminated by major US news organisations.

That study, by the American Heart Association's academic journal, has been retracted this month, according to reporting by Vice News, under a cloud of criticism from the Journal’s editors and other academics and advocates, concerned over alleged shortcomings in its peer-review process and its research subjects.

The study’s authors, Dharma N. Bhatta , and Stanton A. Glantz, were criticised in a statement by the Journal of the American Heart Association (JAHA) editors “concerned that the study conclusion is unreliable.” The JAHA retracted the paper after Brad Rodu, a tobacco control specialist at the University of Louisville, noted that many of the respondents the study had analysed were also current or former smokers, making their risk of heart attacks more likely from their use of combustible tobacco prior to and during vaping.

Rodu’s criticisms were supported by several other academics from public health schools including King’s College London, Yale and New York University who co-signed a letter to the JAHA requesting an investigation.

Advocates for harm reduction such as vaping have argued that compromised scientific studies like the retracted JAHA research, have fed into a climate of moral panic in the US, where legislators have raced to enact belated regulations considered punitive of the vaping industry there and misleading to consumers.

Dr David Abrams, a Global Public Health professor at New York University, has stated that the current panic about vaping in the US jeopardises one of the best chances in over a century to finally “get rid of the cigarette” and save millions of lives.

Vapers in the UK and EU are protected by the Tobacco Products Directive (2016) and a raft of other regulations designed to prevent any risk to users of e-liquids, e-cigarette devices and nicotine-containing products, and to ensure quality and safety. Our industry’s rigorous adherence to and support for these standards have made vaping the safest way to reduce dependence on traditional tobacco. Public Health England have taken the position that vaping is 95% safer than smoking and are joined by many other health bodies and charitable organisations including King’s College London and Cancer Research UK.

At Vapouriz, we believe in providing vapers with a safe, quality product, one that meets stringent toxicological tests set by the Medicines and Healthcare Products Regulatory Agency (MHRA) and conforms to TPD regulations.

As one of the largest e-liquid manufacturers in the UK, all of our e-liquids are produced in ISO Class 7 certified cleanrooms at our purpose-built, state-of-the-art Vapouriz Labs in Guildford, Surrey. Vapouriz e-liquids contain only food-approved flavourings, nicotine, and propylene glycol and vegetable glycerol, which are all pharmaceutical grade as defined by the European Pharmacopoeia Standard Monograph, and all sourced within the EU.

What should you do if you have concerns about vaping?

-Only buy e-cigarette devices and e-liquid from reputable, TPD-compliant manufacturers and suppliers such as Vapestore.

-Talk to one of our professional customer services specialists for advice and guidance on all aspects of e-cigarettes and vaping at support@vapouriz.com or call 0800 644 0000.

-Talk to your GP or another certified health professional about using e-cigarettes.